Foamix Pharmaceuticals Ltd. EBITDA 2016-2019 | FOMX
Foamix Pharmaceuticals Ltd. ebitda from 2016 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Foamix Pharmaceuticals Ltd. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-75 |
| 2017 | $-65 |
| 2016 | $-30 |
| 2015 | $-17 |
| 2014 | $-2 |
| 2013 | $-1 |
| Foamix Pharmaceuticals Ltd. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2019-09-30 | $-23 |
| 2019-06-30 | $-19 |
| 2019-03-31 | $-16 |
| 2018-12-31 | $-15 |
| 2018-09-30 | $-16 |
| 2018-06-30 | $-19 |
| 2018-03-31 | $-26 |
| 2017-12-31 | $-17 |
| 2017-09-30 | $-18 |
| 2017-06-30 | $-17 |
| 2017-03-31 | $-15 |
| 2016-12-31 | $-11 |
| 2016-09-30 | $-6 |
| 2016-06-30 | $-8 |
| 2016-03-31 | $-5 |
| 2015-12-31 | $-6 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-5 |
| 2015-03-31 | $-3 |
